Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Breast Cancer Res Treat. 2018 Apr 18;170(3):623–631. doi: 10.1007/s10549-018-4774-2

Figure 1.

Figure 1

Levels of personal social support and noninitiation (N=3,382), discontinuation and nonadherence (N=2,687) to AHT in hormone receptor-positive breast cancer patients from the Pathways Study

* The effect estimates are odds ratios (noninitiation) and hazard ratios (discontinuation and nonadherence); the horizontal axis is presented on a log scale. Associations of clinical social support and outcomes were similar in main analyses.